Suppr超能文献

亲和配体大小在细胞外囊泡检测和表征中的作用。

The role of the size of affinity ligands in the detection and characterization of extracellular vesicles.

机构信息

School of Medicine, Deakin University, and IMPACT Strategic Research Centre, Waurn Ponds, VIC, 3216, Australia.

Laboratory of Tumor Molecular and Cellular Biology College of Life Sciences, Shaanxi Normal University 620 West Chang'an Avenue, Xi'an, Shaanxi, 710119, China.

出版信息

Biosens Bioelectron. 2024 Aug 15;258:116381. doi: 10.1016/j.bios.2024.116381. Epub 2024 May 11.

Abstract

Surface proteins on the membrane of nano-sized extracellular vesicles (EVs) not only play crucial roles in cell-to-cell communication, but also are specific binding targets for EV detection, isolation and tracking. The low abundance of protein biomarkers on EV surface, the formation of clusters and the complex EV surface network impose significant challenges to the study of EVs. Employing bulky sized affinity ligands, such as antibodies, in the detection and characterization of these vesicles often result in reduced sensitivity of detection or poor quantification of proteins on the EV surface. By virtue of their small size and high specificity, Affibody molecules emerge as a potential alternative to their monoclonal antibody counterparts as robust affinity ligands in EV research. In this study, we present a theoretical framework on the superiority of anti-HER2 Affibodies over anti-HER2 antibodies in labeling and detecting HER2-positive EVs, followed by the demonstration of the advantages of HER2 Affibodies in accessing EV surface and the detection of EVs through multiple types of approaches including fluorescence intensity, colorimetry, and fluorescence polarization. HER2 Affibodies outperformed by 10-fold over three HER2 antibody clones in accessing HER2-positive EVs derived from different human cancer cell lines. Furthermore, HRP-Affibody molecules could detect EVs from cancer cells spiked into human serum with at least a 2-fold higher sensitivity compared with that of their antibody counterparts. In addition, in fluorescence polarization assays in which no separation of free from bound ligand is required, FITC-labeled HER2 Affibodies could sensitively detect HER2-positive EVs with a clinically relevant limit of detection, whilst HER2 antibodies failed to detect EVs in the same conditions. With the demonstrated superiority in accessing and detecting surface targets over bulky-sized antibodies in EVs, Affibodies may become the next-generation of affinity ligands in the precise characterization and quantification of molecular architecture on the surface of EVs.

摘要

细胞膜表面纳米级细胞外囊泡 (EVs) 的表面蛋白不仅在细胞间通讯中发挥着关键作用,而且还是 EV 检测、分离和追踪的特异性结合靶标。EV 表面蛋白标志物的丰度低、形成簇和复杂的 EV 表面网络,给 EV 的研究带来了巨大的挑战。在检测和表征这些囊泡时,使用体积庞大的亲和配体(如抗体)通常会导致检测的灵敏度降低或 EV 表面蛋白的定量效果不佳。由于其体积小、特异性高,Affibody 分子作为单克隆抗体的替代品,作为 EV 研究中的强大亲和配体具有很大的潜力。在本研究中,我们提出了一个理论框架,阐述了抗 HER2 Affibodies 在标记和检测 HER2 阳性 EV 方面优于抗 HER2 抗体,随后通过实验证明了 Affibodies 能够更有效地接近 EV 表面,并通过多种方法(包括荧光强度、比色法和荧光偏振法)检测 EV。与三种 HER2 抗体克隆相比,HER2 Affibodies 在接近源自不同人癌细胞系的 HER2 阳性 EV 方面的效果提高了 10 倍。此外,与抗体相比,HRP-Affibody 分子能够以至少 2 倍的更高灵敏度检测到人血清中添加的癌细胞来源的 EV。此外,在不需要游离配体与结合配体分离的荧光偏振测定中,FITC 标记的 HER2 Affibodies 可以灵敏地检测到具有临床相关检测限的 HER2 阳性 EV,而在相同条件下,HER2 抗体无法检测到 EV。Affibodies 在 EV 中比体积庞大的抗体更有效地接近和检测表面靶标,这表明它们可能成为 EV 表面分子结构精确表征和定量的下一代亲和配体。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验